Procaps Group S a (PROCF) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access PROCF Annual Cash Flow →
The quarterly cash flow data below helps track how Procaps Group S a's liquidity profile has evolved over recent quarters.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2024)
12 Months
(Dec 31 2023) 0 0 0
Operating Activities
Income-84.59
Depreciation & amortization0.00
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss0.03
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets1.06
Share-based Compensation0.00
Income (Loss) from Equity Method Investments17.83
Adjustments For Unrealised Foreign Exchange Losses Gains20.31
Adjustments For Depreciation Of Right Of Use Assets-
Adjustments For Amortization Of Intangibles-
Adjustments For Income Tax Expense-
Finance Expenses-
Adjustments For Sharebased Payments-
Adjustement For Share Of Result Of Joint Ventures-
Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss Inventories-
Adjustments For Gain Loss On Disposals Intangibles-
Adjustments For Decrease Increase In Amounts Owed To Related Parties-
Adjustments For Increase Decrease In Current Tax Liabilities-
Adjustments For Increase Decrease In Other Liabilities-
Adjusments For Increase Decrease For Provisions-
Other Financial Asset-
Dividends Received Classified As Operating Activities-
Income Taxes Paid Refund Classified As Operating Activities-
Income taxes0.00
Purchase Of Intangible Assets Classified As Investing Activities5.64
Accounts Receivable0.00
Accounts Payable0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities88.43
Investing Activities
Capital Expenditures19.38
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans5.36
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments1.79
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-26.76
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-50.40
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow107.80
Total Cash Flow11.27
4 historic quarters locked

Sign in to unlock the full Procaps Group S a cash flow history.

About Sofgen Pharma S A Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 20-F filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001213900-26-028293

Figures are derived from filed reports and may be restated. Historical data is subject to revision.